Overview

Update
Total Equity Funding
$26.7M in 1 Round from 9 Investors
Most Recent Funding
$26.7M Series C on November 24, 2009
Headquarters:
Abingdon
Description:
Oxagen is a biopharmaceutical company developing small molecule drugs addressing asthma, and chronic allergic and inflammatory conditions.
Founders:
Categories:
Pharmaceutical, Biopharma, Biotechnology
Website:
http://www.oxagen.co.uk

Company Details

Update

Oxagen Limited, a biopharmaceutical company, provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases. Oxagen Limited was founded in 1997 and is based in Abingdon, the United Kingdom.

Funding Rounds (1) - $26.7M

Update
DateAmount / RoundValuationLead InvestorInvestors
Nov, 2009$26.7M / Series C9

Current Team (4)

Update

Board Members and Advisors (3)

Update

News (2)

Update

Offices/Locations (1)

Update
  • Office

    91 Milton Park

    Abingdon, OX14 4RY

    GBR

Past Team (3)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos